Purchase to unlock title

Summary

CHAPTER 1: TRIPS and Essential Medicines: Must one size fit all? Making WTO responsive to the Global health Crisis @ Page 35 CHAPTER 2: The TRIPS waiver as a recognition of Public health Concerns in the WTO @ Page 56 CHAPTER 3: Public Law Challenges to the Regulation of Pharmecetical Patents in the US bilteral Free Agreements @ Page 77 CHAPTER 4: Global Health and Development: Patents and Public Interest @ Page 101 CHAPTER 5: The Health Impact Fund: Better Pharmaceutical Innovations at much Lower Prices @ Page 135 CHAPTER 6: The Health Impact Fund : a Critique @ Page 155 CHAPTER 7: A Prize system as a Partial Solution to the Health Crisis in the Developing World @ page 181 CHAPTER 8: Innovation and Insufficient Evidence: the Case for a WTO-WHO Agreement on health Technology safety and Cost-Effectiveness Evaluation @ Page 209 CHAPTER 9: Opening the dam: Patent pools, Innovation ad access to Essential Medicines @ Page 235 CHAPTER 10: Open Source Drug Discovery: a Revolutionary Paradign or a Utopian Model? @ Page 263 CHAPTER 11: Accessing and Benefit Sharing avian influenza viruses through the World Health Organization: a CBD and TRIPS Compromise thanks to Indonesia's sovereignty Claim? @ Page 284 CHAPTER 12: The Lazarus Effect: the (RED) Campaign and Creative Capitalism @ Page 313 CHAPTER 13: Beyond TRIPS: the role of Non-state Actors and Access to essential Medicines @ Page 343 CHAPTER 14: Securing Health Through Rights @ Page 357 CHAPTER 15: The role National Laws in Reconciliation Constitutional right to Health with TRIPS obligations: an Examination of the Glivec patent case in India @ Page 381 CHAPTER 16: Tipping Point: Thai Compulsory Licences Redefine Essential Medicines Debate @ Page 406